Finance Supplement Maker Timeline Raises $66M Amid Longevity Wave Courtney Rehfeldt January 24, 2024 Share on Facebook Share on Twitter Share via Email credit: Timeline Subscribe Now Log in A promising age-fighting ingredient in Timeline’s products has attracted big-time investors in L’Oréal and Nestlé Consumer health biotech company Timeline has raised $66 million in a Series D financing round which included strategic investments from L’Oréal and Nestlé. Switzerland-based Timeline offers nutritional supplements and topical skin health products with Mitopure, a proprietary ingredient (Urolithin A) that promotes healthy aging and is supported by 15-plus years of research, the company says. The global corporate venture capital fund of L’Oréal led the funding round, which will go towards expanding Timeline’s product categories and markets across food, beauty and health while remaining longevity-focused. “This strategic collaboration reflects the breakthrough multidimensional approach that we’ve always believed is necessary to make meaningful advancements for longevity and healthspan,” said Patrick Aebischer, co-founder and chairman of Timeline. “I want to thank L’Oréal, Nestlé and our longstanding investors for their commitment to longevity solutions rooted in the highest level of science.” Longevity is a new definition of beauty, points out Barbara Lavernos, deputy CEO who leads research, innovation and technology at L’Oréal. “Longevity is about living healthier for longer, and L’Oréal has been working for a decade to understand and anticipate what this could mean for beauty,” Lavernos said. “Our investment in Timeline is exciting for its potential to transpose key hallmarks of longevity onto skin health and beauty.” Timeline currently sells soft gel supplements and powder packets to promote energy, strength, and endurance, as well as a serum and day and night creams for the skin for youthfulness and radiance. All of Timeline’s products contain the recommended dose of Mitopure. “We have been an investor in Timeline since 2019 and continue to be very impressed with the team and stand behind the exponential potential that the Mitopure technology holds for nutrition to help people age better,” said Anna Mohl, CEO of Nestlé Health Science. “We’re excited to have L’Oréal join as an investor and strategic partner to bring this technology to new heights and extend its applications.” Timeline’s Mitopure attracted one famous entrepreneur’s mom — Maye Musk, Elon’s mother. The dietitian promoted the company in 2021 when she signed on as spokesperson.A promising age-fighting ingredient in Timeline’s products has attracted big-time investors in L’Oréal and Nestlé Consumer health biotech company Timeline has raised $66 million in... Membership Required You’ve reached your 3-article monthly limit. Subscribe to ATN Pro for unlimited access to industry-leading coverage, insights, and analysis shaping the future of fitness and wellness. ATN Pro members get: Unlimited access to Athletech News articles Exclusive access to ATN Pro-level reporting Discounts to ATN the Innovation Summit VIP access to community events Exclusive email newsletters Subscribe Now Already a member? Log in Already a member? Log in here Tags: Funding Longevity Nestlé Supplement Companies Wellness Trends